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Abstract

Felemban, Dalal. M.S. Department of Biological Sciences, Wright State
University, 2016. The Effects of Cold and Freezing Temperatures on The
Blood Brain Barrier and Aquaporin 1, 4, and 9 Expression in Cope’s Gray
Treefrog, Hyla chrysoscelis.
In sub-freezing temperatures, cerebrospinal fluid (CSF) and blood
plasma within the brain of freeze-tolerant gray treefrogs, Hyla chrysoscelis,
are likely to freeze. We hypothesized that this would challenge blood-brain
barrier (BBB) integrity and volume regulation for cells in the brain. Our
first hypothesis, tested as cerebral Evans blue permeability, was not
supported; BBB integrity appeared uncompromised by cold. Our second
hypothesis, tested as changing expression of aquaporin (AQP) proteins, was
partially supported. Whole-brain expression (Western blot) of AQP1 and
AQP4 were unchanged by cold conditions, but AQP9 expression increased
in thawed animals. AQP1 was found (immunohistochemistry) in ependymal
cells, endothelial cells, neurons, and astrocytes, AQP4 and AQP9 in neurons
and astrocytes. Cell localizations of AQPs were not changed by thermal
conditions, but cold conditions did enhance immunofluorescence intensity.
iii

The brain of gray treefrogs is protected from damage during freezing.
Changing expression of AQPs may protect cells during cold-induced
osmotic challenges.

iv

TABLE OF CONTENT
Page
Introduction and aims………….……….………………...…..… 1
Freeze tolerance.. ..……………………………….. ……..1
Blood brain barrier.…………………………………….....4
BBB Functions in Normal and Pathological Brain
conditions………………………………………......7
Aquaporins …………………………………………….... 8
Study Goals and Hypothesis ………………………….....13
Specific Aims.…………………………………………...15
Material and methods…………..….…………………………...16
Animal collecting……………………………………......16
Cold and freezing acclimation……………………….….16
Evaluation of BBB disruption……………………….…..18
Protein isolation and Western Blottin…………………....21
Histology …………………………………………….….23
Immunostaining …………………………………….…...25
Statistics ………………………………………………....33
Results….…..……………………………………………….......34
v

Blood Brain Barrier Integrity………………………….…34
AQP1, 4, and 9 protein expression.…………………........34
HC-1 expression……………………………………….…34
AQP4 expression…………………………………………35
HC-9 expression………………………………………….36
AQP1, 4, and 9 protein localizations in brain cells…...….37
HC-1 localizations in brain cells……………………..…..37
AQP4 localizations in brain cells……………………...…39
HC-9 localizations in brain cells………………………....40
Double immune labeling……………………………...….41
Triple immune labeling………………………………......42
Discussion…………………..……………………………...........43
The Blood-Brain Barrier…………………………..…......43
Aquaporin expression……………………………………46
Conclusion…………………………………………………...…55
References…..……………………………………………...….111

vi

LIST OF FIGURES
Figure number

Page

1. The structure and function of the Blood–Brain Barrier……6
2. The basic structure of AQPs………………………………10
3. Cold and freezing acclimation and
Evans Blue injections………………………………...20
4. Clustal alignment of the AQP4 homolog
HC-4 and a commercially available AQP4
polyclonal antibody…………………………………...23
5. Coronal sections from frog brai.……………………….….29
6. Mouse brain tissue stained with hematoxylin and eosin.....31
7. Hyla chrysoscelis brain tissue stained with
hematoxylin and eosin………………...……….….…32
8. Evans blue experiment to assesse BBB integrity
under different physiological conditions……………..59
9. Western blots presenting HC-1 protein
expression in whole brain from
different physiological conditions…………….…....…60
10. Test for glycosylation of HC-1…………………....….….63
11. Western blots presenting AQP4 protein
expression in whole brain from different
physiological conditions……………………….……..68
vii

12. Test for glycosylation of AQP4…………………………...70
13. Western blots presenting HC-9 protein
expression in whole brain from different
physiological conditions…………………………….….73
14. Test for glycosylation of HC-9……………………………76
15. HC-1 localization in endothelial cells and ependymal
cells in anterior brain close to LV………………….…..82
16. HC-1 localization in endothelial cells, ependymal cells,
neurons, and astrocytes in posterior brain…………..…..85
17. Co-localization of HC-1 with glial
fibrillary acidic protein (GFAP) on
ependymal cells, neurons, and astrocytes…………...…89
18. AQP4 localization in neurons and astrocytes
in anterior brain close to LV………………………..…..92
19. AQP4 localization in neurons and astrocytes in
posterior brain…………………………………….....…96
20. Co-localization of AQP4 with glial fibrillary
acidic protein (GFAP) on neurons, and astrocytes...…...99
21. HC-9 localization in neurons and astrocytes
in anterior brain clos to LV……………………..……..102
22. HC-9 localization in neurons and astrocytes
in posterior brain close to AQ……………………..…..105
23. Co localization of HC-1, AQP4, and HC-9 in
viii

neurons and astrocytes………………………………..108

ix

LIST OF TABLES
Table number
Page
1. Summary of the cellular localization of HC-1
in anterior brain from different physiological
conditions and illustrates the fluorescence signal
intensity differences between conditions………………….84
2. Summary of the cellular localization of HC-1
in posterior brain from different physiological
conditions and illustrates the fluorescence signal
intensity differences between conditions……………….…88
3. Summary of the cellular localization of AQP4 in
anterior brain fromdifferent physiological conditions
and illustrates the fluorescence signal
intensity differences between conditions……………….…95
4. Summary of the cellular localization of AQP4 in
posterior brain from different physiological conditions
and illustrates the fluorescence signal
intensity differences between conditions………………....98
5. Summary of the cellular localization of HC-9 in
anterior brain from different physiological conditions
and illustrates the fluorescence signal
intensity differences between conditions………………...104
6. Summary of the cellular localization of HC-9 in
posterior brain from different physiological conditions
and illustrates the fluorescence signal
intensity differences between conditions…………….…..106
7. Summary of the cellular localization of HC-1,
AQP4, and HC-9 in mid-brain from different
physiological conditions and illustrate the
x

fluorescence signal intensity differences
between condition……………………………………......107

xi

1.0 Introduction
1.1 Freeze tolerance
Surviving in cold climates forces an organism to face many
environmental challenges, including reduced access to food, shorter summer
periods, and subfreezing temperatures in the winter season. Many small
vertebrate species hibernate under water or under ground to avoid freezing
temperatures. However, some species hibernate in damp or less isolated
areas and are not protected from freezing. These animals must find a way to
deal with several internal physiological challenges that result from freezing
temperatures. For instance, metabolism decreases overall and is limited for
selected functions. Oxidative stress may result from the unstable blood flow
that occurs with repetitive freezing and thawing. Further, physical damage
may occur due to ice formation, particularly if ice forms inside the cells.
“Freeze tolerance” requires a combination of adaptations to protect an
organism against the harmful effects of freezing (Story and Story, 1992,
Costanzo et al., 1995; Story and Story, 1996).
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One important component of freeze tolerance is to minimize physical
damage by limiting ice formation to the extracellular fluids. As the
extracellular fluids freeze, pure water becomes solidified as ice, thereby
increasing the concentration of the extracellular solutes, creating a hyperosmotic environment that draws water from the cell. This causes a reduction
in intracellular water and volume, shrinking the cell. On the other hand,
once the ice thaws, the melted water dilutes the extracellular solutes,
potentially creating a hypo-osmotic extracellular environment resulting in
water diffusing to the inside of the cell. This causes the cell to swell. This is
physiologically stressful with repeated cycles of shrinking and swelling due
to freezing and thawing, respectively. Therefore, animals that would be
repeatedly exposed to freezing temperatures must have physiological
adaptations, such as a mechanism to control water flux, that allow them to be
freeze tolerant in subfreezing environments (Costanzo et al., 1992; Storey
and Storey 2004; and Storey and Storey 2013).
There are a number of strategies that an organism may be able to use
to survive the osmotic challenges presented by sub-freezing temperatures.
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One of these is to accumulate cryoprotective solutes. Cope’s gray treefrog
(Hyla chrysoscelis) is one of the identified species of freeze tolerant frogs.
These frogs are able to survive freezing for weeks and recover rapidly.
During the cold, gray treefrogs accumulate glycerol as a cryoprotectant, and
at the time of freezing they liberate glucose. These solutes are thought to be
derived from glycogen in the liver and they accumulate in the blood and are
distributed to different organs within body (Storey and Storey, 1984).
Glucose or glycerol work as cryoprotectants to prevent cell damage during
freezing (Krane and Goldstein, 2007). Additionally, these frogs redistribute
body fluids in order to protect cells from freeze damage (Lee et al., 1992).
Another strategy involves the expression of aquaporins. Aquaporins
are protein channels in the plasma membrane that serve to facilitate and
control the passage of water and, in some cases, small organic solutes.
Aquaporin-facilitated water flux has been a mechanism suggested to be used
by bacteria that allow them to survive rapid freezing. The critical role of
aquaporins in controlling cell volume and responding to osmotic changes
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may have resulted in the selective pressure that caused these proteins to be
retained and diversify with evolution (Tanghe et al., 2006).
When gray treefrogs freeze, the bulk liquids in the brain, including the
blood plasma and the cerebrospinal fluid (CSF), are likely to freeze. The ice
formation in extracellular space creates significant challenges including cell
damage or cell volume changes. Furthermore, the blood-brain barrier (BBB)
could be compromised as well by glucose released at the time of freezing or
by physical damages. How do neural tissues survive these stresses?

1.2 Blood-Brain Barrier
The concept of the blood-brain barrier (BBB) was established more
than 100 years ago as the vascular barrier between the circulating blood and
the central nervous system (CNS). In the 1880s, Paul Ehrlich observed that
certain dyes injected into the vascular system were able to stain all organs
except the brain and spinal cord. At the time, Ehrlich suggested that these
findings were due to the dyes’ lack of affinity for the nervous system.
However, an associate of Ehrlich, Edwin E. Goldman, noted that the same
4

dyes were able to successfully stain nervous tissue, but not any other tissue,
when injected directly into the cerebrospinal fluid. This indicated that there
was some form of barrier that was preventing access of the dyes to the CNS
from the vascular system. Moreover, other studies have demonstrated that
certain neurotoxic agents are only capable of affecting the brain when
injected directly into the brain. Taken together, these observations suggested
that there is a barrier that separates the brain from the rest of the body,
including the vasculature. Indeed, the BBB serves as this gate and controls
the molecules transferred between the CNS and the blood (Engelhardt, 2003;
Engelhardt and Sorokin, 2009).
The small blood vessels of the brain have unique characteristics that
form the BBB. The structure of the BBB is composed of three types of cells:
endothelial cells, astrocytes (specifically the end feet) and pericytes (Fig. 1).
The adjacent endothelial cells form complex tight junctions (TJs) that
selectively prevent most of the molecules in the blood circulation from
crossing the vessel wall into the brain tissue (Fig. 1). Further, the pericytes
play a key role in angiogenesis, structural integrity and differentiation of the
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vessel, as well as formation of the endothelial TJs. Astrocytes contribute to
the BBB particularly through their end feet structures (Loreto and Reggio,
2010). Each of these three cell types are believed to be significant for the
normal function and stability of the BBB (Ballabh et al., 2004).

Fig 1: The structure and function of the Blood–Brain Barrier (BBB).
(A) Brain barriers. (B) BBB structure. (C) BBB Transport. (D) Tight
junctions complex. (Adapted from Aday et al, 2016)
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1.3 BBB Functions in Normal and Pathological Brain conditions
Under normal circumstances, the BBB regulates the homeostatic
environment of the mammalian brain and spinal cord by allowing only
specific and limited small solutes to cross the CNS. Small lipophilic
molecules, such as oxygen and carbon dioxide, are able to cross the plasma
membrane based on their concentration gradient. Other molecules, for
instance glucose and amino acids, need specific transporters to enter the
brain; certain macromolecules like insulin, leptin, and transferrin cross the
CNS through receptor-mediated endocytosis (Fig1) (Ballabh et al., 2004,
Pardrige, 1999, and Negy et al., 1987).
This strict BBB barrier can be altered by CNS injuries such as
ischemia, hemorrhage, or traumatic injury. For example, cerebral ischemia
caused by a stroke can result in increased permeability of the BBB, leading
to the influx of fluid into the brain (i.e., edema) (Kim et al., 2009).
Lossinskyan and Shivers (2004) described that animals exposed to factors
such as injury, cold lesion, and inflammatory conditions showed alterations
in the normal structure and function of BBB. Animals such as mice, cats,
7

and gerbils that were subjected to cold lesion injury displayed BBB
disruption revealed by injection with protein tracers (Lossinsky and Shivers,
2004). Additionally, inflammatory conditions of the BBB, including
exposure to toxic or hypertonic compounds, were shown to increase the
permeability of the BBB (Lossinsky and Shivers, 2004). Shivers (1978)
showed through tracer analyses that hyperglycemia could increase
permeability, thereby disrupting the BBB in the lizard brain.

Kim et al. (2009) assessed the BBB disruption in mouse brains during
a study to evaluate the effectiveness of the drug agmatine for brain edema.
They observed that agmatine could attenuate edema by reducing BBB
disruption, specifically by down-regulating expression of specific proteins
involved in regulating fluid transport across blood vessels. These proteins
known as aquaporins (AQP), belong to a family of molecules responsible for
transporting water and other solutes (i.e., glycerol) across cells in the BBB,
as well as many other cell types.
1.4 Aquaporins
AQP proteins form a family of membrane proteins that confer
8

permeability to water and, in many cases, other small molecules.
Aquaporins are expressed in the cell membrane as tetramers. The structure
of each monomer includes six transmembrane alpha-helices with five
interhelical loop regions (A-E). The amino and carboxyl termini lay on the
cytoplasmic side of the membrane. The two halves of each aquaporin
monomer fold back on each other to form a pore that provides the
permeability pathway. The four monomers together form an additional pore
in the tetramer that may add to the permeability properties (Gonen & Wals,
2006; Benga, 2009; Buffoli, 2010).

9

Fig 2: The basic structure of AQPs. The monomer includes six
transmembrane alpha-helices with five interhelical loop regions (A-E). The
amino and carboxyl termini lay on the cytoplasmic side of the membrane.
The two halves of each aquaporin monomer fold back on each other to form
a pore. (Picture adapted from Nagelhus and Ottersen, 2013)

Different organisms express different numbers of aquaporins.
Humans express 13 proteins, designated as AQP0-12. The different peptide
10

sequences in these AQPs create different type pore sizes. Therefore, AQPs
are classified into three sub-groups according to their permeability. The first
sub-group is Aquaporins (AQP0, 1, 2, 4, 5, 6 and 8) that only allow water to
pass. The aquaglyceroporin sub group including AQP3, 7, 9, and 10 is
permeable to water and also to other molecules such as glycerol and urea.
The last sub-group is the super-aquaporins (AQP11, 12) that are found in the
cytoplasm and might have roles in water intracellular transport (Buffoli,
2010, Badaut et al., 2014). Amphibians express homologs of these human
aquaporins.
AQP1, 3, 4, 5, 6, 8, 9, and 12 were reported in brain tissues (Badut et
al., 2014). AQP1, 4, and 9 appear to be the most significant AQPs in brain.
The distribution of these three AQPs has been identified in normal and
pathogenic brain in many studies.
Under normal conditions in mammalian brain, AQP1 is found mainly
at the apical surface of the choroid plexus epithelium and, to a lesser extent,
in the basolateral membrane of the endothelium, where it plays an important
role in cerebrospinal fluid secretion (Loreto and Reggio, 2010).
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Furthermore, AQP1 was localized in dorsal horn of spinal cord, and the
trigeminal sensory ganglia, which indicate that it may play role in
nociception (Badaut et al., 2014). In contrast, under pathological conditions
AQP1 is expressed in other tissues sites where water transport is
upregulated, such as in cerebral vessel endothelia to clear edema water from
the brain (Loreto and Reggio, 2010). Also, AQP1 was localized in some
neuronal processes in brain septum are increased after brain injuries. AQP1
was found in astrocytes in non-human primate (Badaut et al., 2014).
AQP4 is the most investigated AQP in the brain due to its diverse and
significant roles. AQP4 is the predominant AQP in the CNS and is a crucial
component of the BBB, where it is critical for water homeostasis within the
brain (Loreto and Reggio, 2010, Badaut et al., 2014). It was found in
astrocyte end feet that connected with cerebral vascular endothelia,
especially concentrated in cerebral cortex, where it plays important roles in
water mobility in brain. Under some pathological conditions AQP4
contributes to increasing edema, but at other times it has a role to decrease
edema (Badaut et al., 2014). In addition to water homeostasis function,
AQP4 may play other physiological roles associated with its distribution in
12

other brain tissues such as hippocampus, corpus callosum, cerebellum,
magnocellular nuclei of hypothalamus, and brain stem. For example, studies
of AQP4 knockout mice AQP4 -/- indicate that AQP4 plays a role in cell
adhesion and might influence astrocyte characteristics.
AQP9 is an aquaglyceroporin that transport water and other molecules
such as glycerol, urea, and monocarboxylate. AQP9 was reported in
astrocytes, endothelial cell of sub-pial vessels, and catecholaminergic
neurons. It was found in two forms: 26KDa in the inner membrane of
mitochondria and 30KDa in cell membrane. AQP9 is believed to play role in
neuronal and astrocyte energy by facilitating glycerol and using glycerol as
energetic substrate. (Badaut et al., 2014).
These data suggest that AQP expression contributes importantly to the
function of the BBB, and that AQPs can be key factors to reduce or
compensate for BBB disruption in CNS injuries.

1.6 Study Goals and Hypothesis
A variety of experimental and pathological conditions can lead to
13

damage or changing properties of the BBB in rodents and other animals. We
hypothesize that cold and, especially, freezing temperatures will break the
BBB and increase the AQPs expression. The Cope’s gray treefrog Hyla
chrysoscelis serves as a natural model for such research as it can withstand
the extreme cold or freezing temperatures and survive/recover. During
acclimation to cold and freezing temperatures, the circulation and blood flow
decreases, which may, to an extent, mimic ischemia conditions. Moreover,
freezing states cause an increase in osmolality outside cells including the
endothelial cells of BBB due to ice formation. In turn, this causes the cells to
shrink, which may impact BBB permeability by potentially disrupting TJs.
Additionally, AQPs expression may alter in order to control water flux
during the repeating cycle of freezing and thawing. To test my hypothesis, I
propose the following two specific aims to assess whether the stability of the
BBB is compromised under cold or freezing conditions and whether AQP
expression is altered.
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1.7 Specific Aims
Aim 1: I assessed BBB integrity in Hyla chrysoscelis using Evans blue
tracer analysis in animals acclimated to 5˚C (cold-acclimation) and animals
exposed to -2.5˚C (frozen and thawed) in comparison with animals held at
ambient laboratory conditions (~22˚C).

Aim 2: I evaluated the expression of AQP1, 4, and 9 protein in brains of
Hyla chrysoscelis acclimated to 5˚C only and animals exposed to -2.5˚C, in
comparison to animals held at ambient laboratory conditions (~22˚C).
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2.0 Material and methods:

2.1 Animal collecting
Cope’s gray treefrogs, Hyla chrysoscelis, were collected from
breeding sites in Greene County, Ohio, USA. Animals were transferred to
the laboratory animal housing facility at Wright State University and housed
individually or in pairs using standard housing conditions (60 cm × 30 cm ×
30 cm cages with vented tops). The habitat’s photoperiod was set to 12 h:12
h light/dark, and the temperature was set to a constant 22 °C. Animals were
allowed free access to water and were fed crickets ad libitum twice per
week.
All animal experiments were performed in accordance with and
approved by Wright State University’s Institutional Animal Care and Use
Committee.

2.2 Cold and freezing acclimation
Frogs were divided into four groups representing different
physiological conditions (warm acclimated, cold acclimated, frozen,
16

thawed/post-freeze recovery). One group was held in standard housing at
22˚C (warm acclimated, control group). The remaining animals were
transferred to a cold room to start the cold acclimation process.
Temperatures were adjusted gradually from 20˚C to 5˚C over an eight
weeks span. Animals had access to water and were fed crickets until they
naturally stopped feeding at ~10˚C. Cold-acclimated animals were
maintained at 5˚C, and some these cold-acclimated animals were then frozen
or frozen and subsequently thawed.
The freezing process took one week where the temperature decreased
~1˚C/day (2, 1, 0, -1, -2, -2.5˚C). When the temperature reached -2.5˚C, a
piece of ice was touched to a cold moistened gauze pad on which the frog
rests, and the frog quickly became frozen. The frozen group was killed after
24 hours at -2.5˚C, and the thawed group was returned to 5˚C for 24 h to
recover before being killed to evaluate the possible damages from freezing
(Fig2).
Brains were collected from each condition for analysis by histology,
immunofluorescence, and immunoblotting.
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2.3 Evaluation of BBB disruption
Blood-Brain Barrier (BBB) disruptions were assessed using Evans
Blue (EB) as a nontoxic high-molecular weight vascular permeability
marker. It provides a rapid and reliable assessment of global BBB
permeability. EB binds to albumin in the blood and it is an indicator for
BBB disruption if it is observed in the brain (Kaya and Ahishali, 2011).
A 1% EB solution was prepared by dissolving EB (Sigma, St. Louis,
MO) in a physiological saline solution then sterile filtering. The EB solution
was injected intraperitoneally (4 µl/g).
Belayev et al. (1996) examined the injection of EB over various time
courses (3-4-5-26-50 h) 2-3-24-48 h after the onset of middle cerebral artery
occlusion. The authors described no visible areas of EB extravasation,
except in the stroma of the choroid plexus in the brains of the 2-3 h and 2426 h recirculation groups. Therefore, frogs were injected with 1% EB in
saline and that was allowed to circulate for 24 h. Having three different
temperature conditions, however, may pose an issue for EB circulation.
Harri and Talo (1974) demonstrated the impact of temperature on the
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response of an isolated frog's heart. The authors showed that the heartbeats
decreased with lower temperatures, implying that the heartbeat will be less
frequent and blood flow will likely be diminished with lower temperatures
during cold acclimation and the freezing process. Therefore, EB was
allowed 24 h to circulate in order to account for the potential of a slower
blood flow. For the control groups, frogs were injected with 1% EB in saline
for 4 h (Fig3) (Belayev et al., 1996; Kim et al., 2010; Kaya & Ahishali,
2011; Manaenko et al., 2011).
a) Frogs acclimated to ~22˚C were injected with 1% EB in saline 4 h
prior to euthanasia.
b) Frogs acclimated at 5˚C were injected with 1% EB in saline 24 h
prior to euthanasia.
c) Frogs in frozen state were injected at -2˚C with 1% EB in saline to
allow EB to circulate 24 h prior to freezing.
d) Frogs in thawed state were injected at -2˚C with 1% EB in saline to
allow EB to circulate 24 h prior to freezing, then frogs were returned
to 5˚C to thaw for 24 h (Fig2).
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3A

3B

3C

3D

Fig 3: Cold and freezing acclimation and Evans Blue injections. a)
Frogs acclimated to ~22˚C were injected with 1% EB in saline 4 h
prior to euthanasia. b) Frogs acclimated at 5˚C were injected with 1%
EB in saline 24 h prior to euthanasia. c) Frogs in frozen state were
injected at -2˚C with 1% EB in saline to allow EB to circulate 24 h
prior to freezing. d) Frogs in thawed state were injected at -2˚C with
1% EB in saline to allow EB to circulate 24 h prior to freezing, then
frogs were returned to 5˚C to thaw for 24 h.
20

2.4 Protein isolation and Western Blotting
The relative quantitative expression of AQP-1, -4, and -9 in the brain
was estimated by immunoblotting. Immunoblotting was performed using
rabbit anti-AQP polyclonal antibodies and a mouse anti-beta actin
monoclonal antibody (Abcam, Cambridge, MA) for protein loading control
purposes. Frogs were euthanized under anesthesia and the whole brain was
quickly removed, frozen in liquid nitrogen, and stored at −80 °C. Tissues
were homogenized in protein lysis buffer containing protease inhibitor
cocktail, incubated with 1% Triton-X100 and pipet mixed on ice every 10
minutes for 30 minutes, and centrifuged 10 min at 10,000×g (Pandey et al.,
2010). Total protein was quantified using a BCA Protein Assay
(ThermoFisher, Waltham, MA). 20 μg of total protein were added to loading
buffer and separated on a 12% SDS–polyacrylamide electrophoresis gel at
150V for 1.5 h along with prestained protein ladder. Proteins were
transferred to polyvinylidene difluoride (PVDF) membrane, blocked with
5% nonfat dry milk in phosphate buffered saline with 0.5% Tween-20
(PBST), and then incubated with primary antibody in 2.5% nonfat dry milk
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in PBST. The membranes were then treated with Donkey anti-rabbit
secondary antibody conjugated with HRP prepared in 2.5% milk in PBST.
Protein bands on blots were detected using enhanced chemiluminescence
(ThermoFisher, Waltham, MA) and imaged with a Fujifilm LAS-3000
system. Specificity of binding was tested by incubating primary antibody
with a five-fold excess by mass of antigen peptide for 1 h at room
temperature prior to application to the membrane (Pandey et al., 2010).
For HC-1 and HC-9, we used autospecific antibodies directed against
the 16 amino acid peptide sequences at the C-terminal end of HC-1 or CH-9,
respectively. For AQP4 we lacked an autospecific antibody and so we
applied an antibody directed against mouse AQP4. Out of 17 amino acids
against which that antibody was directed, 8 are identical in mouse and frog,
5 are strongly similar (on the Gonnet PAM250 matrix), 3 are weakly similar,
and 1 had zero similarity (Fig 4). To test the adequacy of this antibody on
our frog model, we compared the pattern of protein bands in Western blots
of protein extracted from mouse brain with those from treefrog brain (Fig
11).
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Fig4: Clustal alignment of the AQP4 homolog HC-4 and a commercially
available AQP4 polyclonal antibody (Boster Biological Technology). “*”
means identical match. “:” means strong similar properties. “.” means
weakly similar properties.

2.5 Histology
Brains were dissected from frogs and immediately transferred to
periodate-lysine-paraformaldehyde (PLP) fixative containing 4%
paraformaldehyde, 75% mM Lysine, 37.5 mM sodium periodate, and 10
mM Sodium phosphate dibasic (pH 7.2) (Mclean et al., 1974) at 4°C
overnight. After that, tissues were rinsed with 50% ethanol and dehydrated
with an increasing ethanol series (50%, 70%, 95%, and 100%). Then, tissues
were cleared in xylenes and embedded in paraffin (Humason, 1979). Brain
23

tissues were sectioned using a microtome into 5 µm thick slices (Leica
RM2255 Rotary Microtome, Leica, Germany). Coronal sections were taken
from different regions of the brain (anterior, mid-, and posterior) that where
close to the lateral, third, and optic ventricles, respectively. The brain
regions were identified using frog brain atlas (Fig.5) (Capranica, Llinás and
Precht 1976; and Raucci et al., 2006). Some of these sections were stained
for routine histology with hematoxylin and eosin (H&E) to determine the
desired region and to identify cells types (Fig 6&7) (Humason, 1979), and
photographed with a digital camera attached to a light microscope. Due to
the limited information about frog neuro-histology, cell types were identified
in our frog model by comparing with mammalian histology. We identified
the different cell types based on location of cells, size and shape of cells and
nuclei (Gartner and Hiatt, 2006). Ependymal cell were identified from the
columnar to cuboidal cell shape, large oval to round nucleus close to the
basal membrane, and location surrounding ventricles. Neurons were
identified from the large cell size with large round nucleus. Astrocytes were
identified by the smaller cells size, small oval nucleus, and location close to
blood vessels (Fig 6&7).
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2.6 Immunostaining
AQP localization and distribution in brain tissues were visualized
using immunofluorescence labeling.
Sections serially adjacent to those used for H&E staining were
labeled with one to three aquaporin primary antibodies and fluorophoreconjugated secondary antibodies to visualize and compare aquaporin
expression and localization in brain tissues. For single antibody
immunolabeling, sections were deparaffinized with xylene and rehydrated
by a decreasing ethanol series (100%, 95%, 80%, 60%). After that, sections
were moved to a staining dish containing citrate buffer (10mM Citric Acid,
0.05% Tween 20, pH 6.0) in a 95-100°C water bath for 30 min to recover
the epitopes from formalin fixation. Sections were held at room temperature
for 40 minutes to cool, followed by washing with phosphate buffered saline
(PBS; 0.02 M sodium monobasic phosphate, 0.08 M sodium dibasic
phosphate, 150 mM sodium chloride, pH 7.2). Then, sections were
permeabilized with 0.2% Triton X-100, followed by 1% glycine (pH 8) and
0.1% sodium borohydride (pH 8) to dilute any the remaining formaldehyde.
Sections were incubated with 10% blocking serum solution (10% serum, 4%
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BSA, and 0.05% Tween-20) for 1 h at room temperature to decreased nonspecific binding between primary antibody and specimens, followed by
primary antibody against AQP 1, 4, or 9 diluted in 1% normal goat serum (1:
200 dilution) overnight at 4°C. After overnight incubation, sections were
washed with PBS and labeled with goat anti-rabbit Cy2-conjugated
secondary antibody diluted in 1% normal goat serum (1: 500 dilution) for
1.5 h at room temperature. Nuclei were counterstained with DAPI staining.
Signals were visualized under Olympus FV1000 confocal microscope using
Olympus FluoView ver.1.7a viewer. All images were taken at a standard
setting for Cy2 or Cy3 labeled secondary antibodies and DAPI nuclear stain
and images were digitally enhanced by improving the background to
fluorescence signal ratio. The expression of AQP1, 4, and 9 in brain tissue
under different physiological conditions was compared visually by
comparing the immunofluorescence intensity under the same standard
setting of the confocal microscope. Based on that visual inspection,
immunofluorescence was rated in intensity on a scale of (++++, +++, ++, +,
-), where (++++) represents high intensity or very strong signal, (+++)
represents strong signal, (++) represents weak signal, (+) represents very low
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intensity signal, and (-) represents no or minimal apparent signal. To
determine the specificity of the fluorescence for the anti-aquaporin
antibodies, each antibody was pre-incubated with 200-fold molar excess of
their specific peptides at room temperature for 1 h before application to the
tissues (Pandey et al., 2010).
Extra steps were performed for double- or triple-labeling using same
host primary antibody. After first secondary antibody labeling, sections were
incubated with 5% normal goat serum for 1 h, followed by PBS washing and
30 μg goat anti-rabbit fragmented antibodies for 1 h (Fab Fragments For
Blocking And Double Labeling Of Primary Antibodies From The Same
Host Species". Jackson ImmunoResearch Inc.. N.p., 2016. Web. 16 Dec.
2016).
https://www.jacksonimmuno.com/technical/products/protocols/doublelabeling-same-species-primary/example-c

In addition to labeling with anti-aquaporin antibodies, we also applied
anti-glial fibrillary acidic protein (GFAP) antibody, a marker for astrocytes
in mammals (Agilent, Santa Clara, CA), in an effort to confirm identification
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of astrocytes in immunofluorescence images. Unfortunately, this effort was
not successful because GFAP appeared to be expressed not only in
astrocytes in our frog model, but also by Ependymal cell and neurons (Fig17
and 20).
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Fig 5: coronal sections from frog brain. A) Coronal section from the anterior
brain close to the lateral ventricles. B) Coronal section from the mid brain
close to the third ventricle. C) Coronal section from the back brain close to
optic ventricles and aqueduct. ACP, anterior choroid plexus; AQ,
aqueduct;EN, entopeduncular nucleus; HB, habenula; IN, interpeduncular
nucleus; LEM, lemniscus; LV, lateral ventricle; MOT, medial optic tract;
NA, nucleus accumbens; NI, nucleus isthmi; OT, optic tectum; OV, optic
ventricle; PD, dorsal pallium; PL, lateral pallium; PM, medial pallium;
PONm, magnocellular preoptic nucleus; POR, preoptic recess; SGC, stratum
griseum centrale; SGP, stratum griseum periventriculare; SM, medial
septum; TEGd, dorsal tegmentum; TEL, telencephalon; THd, dorsal
thalamus; TS, torus semicircularis; III, third ventricle. (Pictures were
adapted from Raucci et al., 2006).
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Fig 6: Mouse brain tissue stained with hematoxylin and eosin (H&E)
illustrating the cell types in mouse brain. (adapted from "Dictionary Normal: Caudate - The Human Protein Atlas". Proteinatlas.org. N.p., 2016.
Web. 28 Dec. 2016.
http://www.proteinatlas.org/learn/dictionary/normal/caudate/detail+2/magnif
icat)
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Fig 7: Hyla chrysoscelis brain tissue stained with hematoxylin and eosin
(H&E). A) (4x) coronal section from anterior brain showing lateral
ventricles. B) (4x) coronal section from mid- brain showing third ventricle.
C) (10x) from mid-brain showing the cell types.
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Statistics
One and two factor analysis of variance (ANOVA; Microsoft Excel)
was applied to determine the statistical significance of AQP1, 4, and 9 levels
under different physiological conditions (warm, cold, frozen, and thawed).
The p-value < 0.05 was considered to be significant.
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3.0 Results
3.1 Blood Brain Barrier Integrity
To examine the integrity of the BBB under different physiological
conditions (warm, cold, frozen, and thawed), Evans Blue (EB) was used as
an indicator for BBB disruptions. Specifically, the BBB would be
considered disrupted if EB was present in brain. Control animals (warm
condition) were negative for EB in the brain, as expected. Cold, frozen, and
thawed brains also showed no evidence of EB in all brain areas, even though
EB was found throughout the body cavity. Brains in all conditions presented
as normal color (white to gray) (Fig 8).

3.2 AQP1, 4, and 9 protein expression

3.2.1 HC-1 expression
Immunoblots of HC-1 yielded a pattern of 28 kDa and 43 kDa bands
from all brain tissues. To confirm antibody specificity, the anti-HC-1
antibody was incubated with HC-1 peptide (where the peptide would
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neutralize the antibody) after which the antibody was unable to bind HC-1 in
the Western blot and the 28 kDa and 43kDa bands were no longer
visualized, confirming the antibody’s specificity for HC-1 (Fig 9).
Protein extractions were treated with N-glycosidase, an enzyme that
cleaves the n-linked glycan molecule, to test if the higher molecular weight
band represented glycosylated protein (Hendriks et al., 2004; Lu et al., 2008;
and Takata et al., 2008). The higher molecular weight band (43 kDa)
disappeared after treatment with N-glycosidase enzyme, indicating that it did
represent glycosylated protein (Fig 10).
HC-1 protein intensity was consistent under different physiological
conditions (warm, cold, frozen and thawed), with no statistically significant
differences between conditions (Fig. 8, p = 0.78).

3.2.2 AQP4 expression
Since we lacked an AQP4 autospecific antibody, we applied an
antibody directed against mouse AQP4. We tested the adequacy of this
antibody on our frog model, by comparing the pattern of protein bands in
Western blots of protein extracted from mouse brain with those from
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treefrog brain (Fig 11). Immunoblots of protein extracted from mouse brain
produced a pattern of five bands (170, 55, 50, 43, and 26 kDa), while the
same anti-AQP4 antibody, applied in our frog model, produced three bands
(55, 50, and 43 kDa) that were similar to those observed for mouse brain.
The common 55, 50, and 43 kDa bands from Western blot, along with the
similar amino acid sequence at the C-terminal end (antibody target) in
mouse AQP4 and treefrog AQP4 homolog (HC-4), suggest that the
commercially available anti-AQP4 polyclonal antibody also targets the
AQP4 homolog in our frog model.
AQP4 proteins were expressed in all frog brain tissues in a pattern of
three bands at 55, 50, and 38 KDa (Fig 11). These bands were not visualized
when the blot was probed with an antibody neutralized with AQP4 peptide.
Treating protein extracts with N-glycosidase prior to Western blotting did
not result in any changes to the immunoblot pattern, suggesting that the three
bands were not representing glycosylated protein (Fig 12). AQP4 expression
did not show any statistical differences between conditions (p = 0.18).

3.2.3 HC-9 expression
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HC-9 proteins were expressed in all brain tissues in a pattern of five
bands at approximately 95, 43, 34, 31, and 26 KDa. These bands
disappeared when the blot was probed with an antibody neutralized with
HC-9 peptide (Fig 13). The 34kDa band mostly disappeared, along with
increase in the 31 kDa band, following treatment of protein extract with Nglycosidase, suggesting the presence of glycosylated protein (Fig14). HC-9
expression was statistically different between cold and thawed conditions (p
= 0.03).

3.3 Localization of AQP1, 4, and 9 proteins in brain cells.
In each physiological condition, AQP1, 4, and 9 proteins were
localized in brain coronal sections taken from different regions (anterior,
mid-, and posterior) close to the ventricles (lateral, third, and optic
ventricles, respectively). (Fig 5)

3.3.1 HC-1 localizations in brain cells
HC-1 was found in ependymal cells surrounding ventricles,
astrocytes, neurons, endothelia cells forming blood vessels and pia mater
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cells. HC-1 localization did not show any apparent changes between warm,
cold, frozen, and thawed animals. However, the intensity of the fluorescence
signal in the cell membrane differed between conditions. The intensity of the
signal was strongest in cold animals (Table1, 2, and 7).
Anterior Brain, Lateral Ventricles (LV)
HC-1 localized strongly to the apical surface of the ependymal cells
surrounding the LV. Cold animals showed the highest intensity of HC-1 in
cell membranes compared to the warm condition. HC-1 was expressed in
endothelial cells of the blood vessels. The protein signal intensity in
endothelial cell membranes was stable through different physiological
conditions (Fig15). The areas close to Nucleus Accumbens (NA) and
Medium Septum (MS) specifically showed HC-1 localization to astrocytes
and neurons (data not shown). The intensity of the HC-1 protein in these cell
membranes was stronger in cold and frozen animals compared to control.
Beside these cell localizations, HC-1 was abundant in pia mater membrane
cells.
Posterior Brain, Optic Ventricles (OV)
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In the posterior brain, HC-1 was expressed in cell types similar to
anterior brain regions, except that HC-1 signals in astrocytes and neurons
were not limited to specific regions. The highest HC-1 fluorescence intensity
was in cold animals (Fig16).
Mid Brain, Third Ventricle (3V)
HC-1 protein was localized to the apical surface of the epithelial cells
that compose the choroid plexus. For other cells, localization was consistent
with the anterior and posterior regions. HC-1 was found in ependymal cells
and tanycytes surrounding the 3V, endothelia of the BBB, neurons, and
astrocytes. Cell membranes from cold animals had a strong HC-1 signal
compared to control (data not shown) (Table7).

3.3.2 AQP4 localizations in brain cells
AQP4 protein was localized to astrocytes that comprise the BBB, and
neurons. The cellular localization of AQP4 did not change between cold,
frozen, and thawed animals, but the fluorescent intensity varied, AQP4
signal was strong in the frozen and cold brain compared to the control, but
was weak under thawed condition (Table 3, 4, and 7).
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Anterior Brain, Lateral Ventricles (LV)
AQP4 was highly prevalent in astrocytes surrounding blood vessels
and in neurons. Neurons were the most abundant cells showed AQP4 protein
on the membrane. The intensity of these signals was strong in frozen animals
compared to control animals. (Fig 18).
Posterior Brain, Optic Ventricles (OV) and Mid Brain, Third Ventricle (3V)
Consistent with the results from the anterior brain, the AQP4 signal
was strong in astrocytes and neurons. However, the fluorescent intensity in
the cell membrane was strong in cold animals compared to control animals
(Fig 19).

3.3.3 Localization of HC-9 in brain cells
HC-9 proteins were localized in neurons and astrocytes. The cellular
localization of AQP9 did not change with the different physiological
conditions, but the fluorescent intensity in the cell membrane was stronger in
thawed animals compared to control animals (Table 5, 6, and 7).
Anterior Brain, Lateral Ventricles (LV)
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HC-9 proteins were found in groups of neurons and astrocytes in
medial septal nucleus and lateral septal nucleus in anterior brain regions.
The thawed animals showed strong HC-9 signal on cell membrane compared
to control (Fig 21).
Posterior Brain, Optic Ventricles (OV) and Mid Brain, Third Ventricle (3V)
AQP9 was slightly detected in neurons and astrocytes in many areas
in the mid- and posterior brain including dorsal thalamus, entopedunular
nucleus, leminiscus, and interpeduncular nucleus. The intensity of HC-9 was
strong in thawed animals compared to control (Fig 22).

3.3.4 Double immune labeling:
In mammals, glial fibrillary acidic protein (GFAP) is used as a marker
of astrocytes. In an effort to further confirm the identity of astrocytes in frog
brain (in addition to using cell morphology and location), we applied antimouse GFAP antibody to some immunohistochemistry analyses. GFAP was
applied along with AQP 1, 4, or 9, using dual labeling immunofluorescence.
GFAP appeared to be expressed not only in astrocytes in our frog
model but also labeled ependymal cell and neurons (Fig 17 and 20).
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Double immune-labeling HC-1 with GFAP
HC-1 and GFAP were co-localized on apical surface of ependymal
cells lining on lateral ventricle, in neurons, and astrocytes (Fig 17).

Double immune-labeling AQP4 with GFAP
AQP4 and GFAP were co-localized on apical surface of ependymal
cells lining on lateral ventricle, in neurons, and astrocytes (Fig 20).

3.3.5 Triple immune labeling:
We tried to co-localize all three AQPs in brain tissue using triple
immune labeling. AQP1, 4, and 9 were co-localized in some specific
neurons and astrocytes in medial septal nucleus and lateral septal nucleus
from the anterior brain (Fig 23).
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4.0 Discussion:
Certain animals, such as frogs, are regularly exposed to cold and
freezing temperatures as part of their normal life cycles. Interestingly,
following being in a frozen state, these animals are able to recover rapidly.
Many of these animals survive the stress of freezing by accumulating
glucose or glycerol as a cryoprotectent and/or redistributing body fluids in
order to reduce the risk of damage associated with freezing.
Freezing would be a challenge for fluid regulation in the brain. The
extracellular liquid and cerebrospinal fluid (CSF) are likely to freeze due to
their water content, and for those animals that accumulate glucose as a
cryoprotectent, the blood-brain barrier (BBB) could be compromised by the
high levels of glucose that are meant to protect during freezing. The
challenges presented with freezing could result in cell damage, BBB
dysfunction, and edema. AQPs may be important in the physiological
response to those challenges and their expression may be altered in response
to cold acclimation and freezing.
4.1 The Blood-Brain Barrier
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Brain injury, infection, and hyperglycemia can all disrupt BBB
function (the review of Lossinsky and Shivers, 2004). Brain disorders that
result from traumatic brain injury (TBI), ischemia, or hemorrhage have been
shown to impact the integrity of the BBB. In a study evaluating the link
between early stage of TBI, AQP4 expression, and the BBB in rat brains,
Hong et al., (2013) reported that the BBB was damaged on a structural level
presenting as swelling of the endothelium, basilar membrane, and astrocyte
processes. Moreover, numerous ischemia studies with rats and mice showed
that the BBB was disrupted and its permeability increased following
ischemia (Belayer et al., 1996, Kim et al., 2010, and Hong et al., 2013).
Brain hemorrhage in mice, either intracranial hemorrhage or subarachnoid
hemorrhage, led to inflammation and BBB disruption and these effects were
reduced or inhibited after treatment with the steroid, methylprednisolone
sodium succinate (MPSS) or propofol (Cheng et al., 2016 and Shi et al.,
2015).
Chronic hyperglycemia has also been shown to alter and disrupt the
BBB in a mouse model of diabetes. The high oxidative metabolism of
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glucose in these animals eventually led to BBB dysfunction (Salameh et al.,
2016, and Zhang et al., 2016).
The present study used the Evans Blue assay to evaluate the integrity
of the BBB in the frog species, Hyla chrysoscelis following exposure to
cold, freezing temperatures and upon recovery from freezing (i.e., upon
thawing). The results described here did not show any evidence of the Evans
Blue dye in the brain of the animals with any temperature condition.
Compared to warm animals (control), the brains from cold, frozen, and
thawed animals displayed in regular frog brain color (white) after dissection
with no evidence of Evans Blue in any areas of the brain. At face value,
these data indicate that there is no disruption to the BBB, as it was able to
exclude the dye from entering the brain.
These results on the BBB integrity in Hyla chrysoscelis under low
temperature conditions were unexpected. We expected the BBB to be
altered, either structurally or functionally. We expected this alteration due to
three reasons: 1.) Frog blood during cold and frozen conditions is known to
contain relatively high concentrations of glycerol and glucose (Croes and
Thomas 2000; Irwin and Lee 2003; and Zimmerman et al., 2007), 2.) The
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cells of the BBB are likely under significant physiological stress with regard
to osmotic pressure from pure freezing and creating concentration gradients
of solutes externally, and/or 3.) The direct physical damage from ice formed
inside blood vessels. There are two possible explanations for the negative
results. First, these results may be accurate and there is no damage to the
BBB, suggesting that these animals have a specific mechanism to resist the
challenges of liquid freezing and glucose accumulation and protect the BBB
in some way. Alternatively, it may be that the Evans Blue assay did not
work well in our model, as this assay is typically performed in mammalian
models and has not been used in frogs previously. To better determine the
latter, it would be critical to have a positive control that induces BBB
disruption in order to examine the applicability of the Evans Blue assay in an
amphibian model.
4.2 Aquaporin expression
Aquaporins (AQPs) 1, 3, 4, 5, 6, 8, 9, and 12 have been identified in
both rodent and primate brains (Buffoli, 2010, Badaut et al., 2014). These
AQPs have been localized to different cells in the CNS in normal and
pathological conditions, such as AQP1 in choroid cells, AQP1, 3, 4, 5, 8,
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and 9 in astrocytes, AQP8 in oligodendrocytes, AQP1, 5, and 8 in neurons,
AQP9 in tanycytes, and AQP1, 4, and 9 in ependymal cells (Buffoli, 2010).
Pervious brain studies reported that the expression of AQP 1, 4, and 9 was
altered under pathological brain conditions including brain injury/trauma,
ischemia, edema, inflammation, and hemorrhage.
In the normal rodent brain, AQP1 is reported to only be expressed in
the epithelial cells of the choroid plexus and has been shown to play a role in
CSF formation (Buffoli, 2010; Kim et al., 2010; McCoy & Sontheimer
2010; Lee et al., 2013; and Qui et al., 2014, Potokar et al., 2016). Moreover,
in the normal non-human primate brain, AQP1 was additionally identified in
the astrocytes end feet surrounding blood vessels and in neurons supplying
the pia mater (Arcienega et al., 2010). Significantly, AQP1 was not found in
endothelial cells of blood vessels in the normal brain (Buffoli, 2010; Potokar
et al., 2016).
Contrary to these published reports on AQP1, my study found that
AQP1 was present in the warm animal brain (control) in ependymal cells
surrounding ventricles, astrocytes, neurons, endothelia cells forming blood
vessels and pia mater cells. AQP1 was expressed in these same cells in cold,
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frozen and thawed animals. However, when visually comparing to the
control, the intensity of fluorescence signals for AQP1 on the plasma
membrane appeared significantly stronger in the cold conditions. However,
Western blot analyses for AQP1 protein expression did not showed any
statistical difference in AQP1 levels between cold, frozen, and thawed
animals when compared to warm (control) animals.
AQP1 has been reported in endothelial cells or astrocytes in the brain
under pathological condition such as brain injury, ischemia, subarachnoid
hemorrhage, or brain tumors (Kim et al., 2010; Qiu et al., 2014). In fact, in
mammals AQP1 localization in endothelial cell was dependent on the
presence of astrocytes close to blood vessels, where AQP1 was only present
in endothelial cells when the blood vessels were not surrounded by
astrocytes, such as in in vitro cultures or brain tumors (Buffoli, 2010). AQP1
expression increased after ischemia and likely works in combination with
AQP4 in causing edema (Lee et al.,2013; Mohammadi & Dehghani 2015;
Kim et al., 2010; Qiu et al., 2014). AQP1 levels were also increased in
choroid plexus tumors (Buffoli, 2010). AQP1 was also detected in
ependymal cells, neurons, astrocytes, and sensory fibers in the spinal cord
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injury (Buffoli, 2010). Taken together, AQP1 in mammals seems to
contribute to pathological brain conditions, such as edema, overproduction
of CSF, and neuronal swelling (Buffoli, 2010; Lee et al.,2013; Mohammadi
& Dehghani 2015; Kim et al., 2010; Qiu et al., 2014). While these published
reports suggest that AQP1 is primarily linked to pathologic states, in our
frog model, AQP1 appears to function more as house-keeping protein that is
not altered or activated with cold and/or frozen temperatures.
AQP4 is the most abundant AQP in brain tissue. In the normal rodent
brain, AQP4 is usually present in glial cells including ependymal cells and
astrocyte end feet close to blood vessels. AQP4 plays a significant role in
water homeostasis in brain tissues and likely plays other roles in the brain
due to astrocyte AQP4 distributes differ in many areas of the brain (Sun et
al., 2003; Badaut et al., 2014; Yang et al., 2015). AQP4 is not expressed in
neurons and endothelial in normal mammalian brain (Sun et al., 2003; Blixt
et al., 2015).
In contrast, our study found that AQP4 was present in neurons, and
astrocytes close to the BBB. The localization of AQP4 was not altered in
cold, frozen, or thawed animals compared to the control. The intensity of
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fluorescence in cell membrane varied between conditions and areas from the
brain. AQP4 signal was strong in the anterior brain in frozen animals while
it was strong in cold animals in the mid- and posterior brain regions
compared to control animals. Western blot analyses did not reveal any
statistically significant differences between conditions.
In mammalian acute brain injuries including ischemia, trauma, and
subarachnoid hemorrhage, AQP4 expression was changed in astrocytes
(Badaut et al., 2014). Previous studies demonstrated that AQP4 contributes
to edema formation in many pathological conditions, including ischemia,
and trauma, such that the diminished level of AQP4 or AQP9 might help to
minimize edema after these injuries (Yang et al., 2015). The type of brain
injury and the time after injury determines the manner of AQP4 regulation in
brain pathology. For example, AQP4 was up-regulated in transient brain
ischemia around the infarct area in mice (Badaut et al., 2001). By contrast,
AQP4 was down-regulated in early stage TBI, likely to protect cells from
cytotoxic edema, and then up-regulated at a later stage to help in the
clearance in vasogenic edema (Blixt et al., 2015). Moreover, Sun et al,
(2003) reported the regulation of AQP4 in a rat TBI model where AQP4
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increased in the trauma area and decreased in the area close to trauma, with
no change in areas distant from trauma. The authors demonstrated that an
increase in AQP4 in astrocyte end-feet in areas damaged by trauma may
help to protect neurons from osmotic stress that may occur by transporting
water from the extracellular space into the astrocytes, causing swelling.
Using the same logic, decreasing AQP4 in areas near the site of damage
could serve to prevent the edema from spreading to other areas. Liang et al.,
(2015) reported that the deletion of AQP4 might be helpful in some diseases,
such as cytotoxic cerebral edema, water intoxication, focal cerebral
ischemia, and bacterial meningitis, while it could be harmful in other
diseases such as in cortical freeze injury, brain tumor, and hydrocephalus.
The authors stated that the AQP4 deletion was beneficial in the acute stage
of micro-TBI in reducing cell death, decreasing edema and decreasing BBB
disruption. As described above, AQP4 regulation in mammals is altered
under pathological brain conditions. The regulation of AQP4 in mammalian
brains under pathological conditions varies depending on the type of injury
and the time after injury. Therefore, it is difficult to determine if AQP4
contributes to or attenuates the effect of injury.
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Based on the findings in mammals, we had predicted that AQP4
expression would increase in the brains of treefrogs subjected to freezing
and thawing. This increase would help to facilitate water movement to the
outside of cells during freezing, and protect from ice forming inside of cells.
However, this hypothesis was only partially supported by our results. We
found that changing temperature conditions resulted in no significant
difference in AQP4 protein expression in the whole brain. However,
immunofluorescence labeling showed differences in signal intensity between
conditions and regions of brain. The signal of AQP4 in anterior was strong
in frozen animals while the signal of AQP4 in mid-and posterior brain was
strong in cold animals. Unfortunately, immunofluorescence is difficult to be
a reliably quantify the change in AQP4 signal intensity between conditions
and from region to another. Notwithstanding, AQP4 might be significant in
water transport during cold, freezing, and thawing to help cells to survive.
Moreover, finding AQP4 in neurons in our frog might be significant
especially considering that neurons in the frog are not protected like those in
mammals. Neurons in the frog during cold, frozen, and thawed conditions
would be expected to face many stresses such cell hydration, and different
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osmotic pressure that require mechanisms to control water transport to and
from cells.
Previous studies reported that AQP9 in the normal rodent brain was
expressed in three types of cells: Glial cells, endothelial cells, and neurons.
The expression of AQP9 in glial cells was detected in the cell body and
processes of astrocytes and in tanycytes. Further, AQP9 expression was
limited only to pial vessel endothelial cells and was not found in vessels
supplying the brain parenchyma. Glia and endothelial localization for AQP9
form the basis for its important role in water homeostasis between the BBB
and CSF. AQP9 was also localized to specific types of neurons known as
catecholaminergic cells and AQP9 has been suggested to play a significant
role in neuron energy by transporting organic molecules such as lactate, and
glycerol (Badaut et al., 2004; Liu et al., 2014; Badaut et al., 2014).
In our present research, AQP9 expression was localized to astrocytes
and specific neurons in control (warm) animals. These neurons were
specifically found in medial septial nucleus and lateral septial nucleus in the
anterior brain. Additionally, AQP9 was minimally detected in neurons and
astrocytes in many areas in the mid- and posterior brain including dorsal
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thalamus, entopedunular nucleus, leminiscus, and interpeduncular nucleus.
Although cold, frozen and thawed animals did not show any changes in
AQP9 cellular localization, thawed animals displayed strong fluorescence
intensity compared to control animals. Western blot analyses confirmed the
immunofluorescent staining results and showed a statistical difference
between cold and thawed animals. High expression of AQP9 was detected in
thawed animals compared to cold animals.
Studies in rodents have reported that AQP9 regulation was altered
under different pathological conditions such as acute injuries, ischemia,
trauma, and hemorrhage (Badaut et al., 2004; Liu et al., 2001; Wang et al.,
2015). AQP9 expression was up-regulated in brain ischemia and this
increase highlights the roles of AQP9 in edema formation and lactate
clearance in the extracellular space (Badaut et al., 2004). Liu et al., (2011)
stated that AQP9 was up-regulated in both early and later stages of TBI. The
authors pointed out the significant roles of AQP9 in edema, lactate, and
glycerol clearance at an early stage and neuronal repair and cellular edema
formation at a later stage. AQP1, 4, and 9 were increased after intracerebral
hemorrhage (ICH) and only AQP4, and 9 were attenuated by curcumin after
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ICH (Wang et al., 2015). The uncorrelated results between AQP9 expression
after ischemic injures and the edema volume suggested that AQP9 did not
contribute in edema after ischemia (Wang et al., 2015). To summarize,
AQP9 was up-regulated in rodent brain disorders and this up-regulation
correlated to clearance of excessive water, lactate, and glycerol that usually
accumulate after brain disorders and also involved in neuron metabolism and
energy by delivering glycerol and lactate.
In our present study, the up-regulation of AQP9 in thawed animals
may relate to the significant role of AQP9 in clearance glycerol that
accumulates in cold stage in order to prepare animals for freezing. At the
same tim e, AQP9-mediated glycerol uptake into neural tissues might be
important in delivering glycerol for neuron metabolism and energy upon
thawing.

5.0 Conclusions
The overall results of this study suggest that freezing did not damage
the BBB in the freeze-tolerant gray treefrog. Aquaporins 1, 4, and 9 were
expressed in many cell types within the brain and are likely to contribute to
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cell volume regulation when extracellular ice forms in the brain. Expression
of AQPs in the brain varied somewhat with condition. These results only
partly support our hypotheses. Additional experiments should be performed
in order to more fully test the hypotheses.
One weakness of this study is that there was no positive control to
demonstrate the effectiveness of the Evans Blue assay in an amphibian
model. Positive control animals that provide BBB disruption by factors such
as hyperglycemia or cold lesion injury might be appropriate with the frog
model. However, finding the proper concentration of glucose in blood to
alter BBB would be challenging, especially given that gray treefrogs use
glucose as freezing cryoprotective chemical. Moreover, cold lesion injury
might be difficult with our model due to the small size of brain. Regardless,
developing a positive control for use with this assay in the frog model would
serve to validate negative results. Additionally, the distribution of the Evans
Blue tracer into the brain is assessed on a gross level with the naked eye.
This may not be a sensitive enough measure for this animal model and
microscopy may be more appropriate to assess subtle differences. Light
microscopy may not be sensitive enough, thus requiring higher
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magnification power like electron microscopy with proper tracers like
horseradish peroxidase (HRP). Electron microscopy may also be able to
detect physical changes in the BBB.
Additionally, it is important to investigate AQP 1, 4, and 9 on both the
mRNA and protein level in each region of the brain to sensitively identify
the exact expression of the various AQPs. This is challenging because the
brains of these animals are small and so it may be difficult to collect enough
protein from the various regions of the brain.
Investigating other AQPs such as 3, 5, 6, 8, and 12 in frog brain tissue
on the protein and mRNA levels might be significant in water transport
during freezing. Also, using more specific antibody markers and histology
staining for brain tissues might be more precise to identify cell types.
Adjustments in the intervals at which these endpoints are assessed
may also be useful. It may be that the frogs recover quickly and any
alterations are missed. Additional or earlier time points may more telling
with regard to disruptions/repair.
Cryogenic lesion studies showed BBB leaking in mice brain, whereas
in our frog model Hyla chrysoscelis BBB was protected in some way from
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cold and freezing temperatures. For that reason, investigating the mechanism
of how these frog protect their BBB from cold and freezing temperatures
could have significant implications for medical control of BBB disruptions
resulting from brain injuries and diseases, or perhaps for regulation of BBB
permeability that could allow treatments to enter brain tissues. Likewise,
disrupted fluid regulation in the brain is a critical component of many brain
injuries. Our findings that AQP expression is altered in specific conditions
and cell types could have implications for therapeutic approaches to edema
and other brain pathologies.
Finally, Gray treefrogs recover mobility and behavior quickly after
they thaw. This impressive recovery indicates that the brain is well
protected from damage during freezing. We have made first steps to identify
the mechanisms that provide that protection.
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Fig 8: Evans blue experiment to assesse BBB integrity under different
physiological conditions. Warm animals (control) showed negative
EB in brain. In Cold, frozen, and thawed animals, brain tissues were
normal white grayish in color, comparable to control, and EB was not
detected in any areas of the brain.
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9 A1

9 B1
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9 A2

9 B2
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9C

Fig 9: Western blots presenting HC-1 protein expression in whole brain
from different physiological conditions. A1&2) HC-1 was expressed in
double bands, a band at 43 kDa and a band at 28 kDa in warm, cold, frozen,
and thawed conditions. B1&2) HC-1 antibody was pre-incubated with its
antigenic peptide. C) Expression of HC-1 was quantified in reference to
actin of frog (n=4). The p-value is 0.78 for ANOVA test at F (3,11)=
0.3651. There are no statistically significant differences for HC-1 protein
between conditions. The error bars represent standard deviation (SD).
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10 B1
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10 A2

10 B2
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10 A3

10 B3
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10 A4

10 B4
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10 C

Fig 10: Test for glycosylation of HC-1. Proteins were treated with Nglycosidase before loaded in 12% SDS-PAGE. A1, 2, 3, and 4) The 43 kDa
bands disappeared with the enzyme treatment while the 28 kDa bands
appeared with the enzyme in stronger intensity in all (warm, cold, frozen,
and thawed) conditions. B1, 2, 3, and 4) HC-1 antibody was pre-incubated
with its antigenic peptide. C) Expression of 28 kDa and 43 kDa bands of
HC-1 protein, with (w) and without (wo) glycosidase enzyme treatment, was
quantified in reference to actin of frog (n=4). The p-value is 0.47 for
ANOVA test at F (3, 44) = 0.8519. There are no statistically significant
differences for HC-1 protein (Glycosylated, and Deglycosylated) between
conditions. The error bars represent standard deviation (SD).
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11 A

11 B
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11 C

Fig 11: Western blots presenting AQP4 protein expression in whole brain
from different physiological conditions. A) AQP4 was expressed in three
bands at 38, 50, and 55 kDa in warm, cold, frozen, and thawed conditions.
B) AQP4 antibody was pre-incubated with its antigenic peptide. C)
Expression of AQP4 was quantified in reference to actin of frog (n=4). The
p-value is 0.18 for ANOVA test at F (3, 11) = 1.977. There are no
statistically significant differences for AQP4 protein between conditions.
The error bars represent standard deviation (SD).
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12 A2
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12 A3

12 A4
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12 B

Fig 12: Test for glycosylation of AQP4. Proteins were treated with Nglycosidase before loaded in 12% SDS-PAGE. A1, 2, 3, 4) The three bands
at 38, 50, 55 kDa with the enzyme treating and without the enzyme appeared
in the similar intensity without any changes in all (warm, cold, frozen, and
thawed) conditions. B) Expression of 38, 50, and 55 kDa bands of AQP4
protein, with (w) and without (wo) glycosidase enzyme treatment, was
quantified in reference to actin of frog (n=4). There are no statistically
significant differences for AQP4 protein between conditions. The error bars
represent standard deviation (SD).
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13 A2

13 B2
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13 C

Fig 13: Western blots presenting HC-9 protein expression in whole brain
from different physiological conditions. A1&2) HC-9 was expressed in five
bands 95, 43, 34, 31, 26 kDa in all (warm, cold, frozen, and thawed)
conditions. B1&2) HC-9 antibody was pre-incubated with its antigenic
peptide. C) Expression of HC-9 was quantified in reference to actin of frog
(n=4). The p-value is 0.03 for ANOVA test at F (3, 11) = 4.231. There are
significant statistical differences for HC-9 protein between cold and thawed
conditions (*). The error bars represent standard deviation (SD).
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14 B2

77

14 A3

14 B3
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Fig 14: Test for glycosylation of HC-9. Proteins were treated with Nglycosidase before loaded in 12% SDS-PAGE. A1, 2, 3, 4) The 34kDa
disappeared with the enzyme treatment and the 31 kDa with the enzyme
appeared stronger intensity. The others bands appeared in slimier intensity
with and without enzyme treatment without any changes in all (warm, cold,
frozen, and thawed) conditions. B1, 2, 3, 4) HC-9 antibody was preincubated with its antigenic peptide. C) Expression of 95, 43, 34, 31 and 26
80

kDa bands of AQP4 protein, with (w) and without (wo) glycosidase enzyme
treatment, was quantified in reference to actin of frog (n=4). The p-value is
0.0001 for ANOVA test at F (3, 44) = 11.50. There is significant statistically
differences for HC-9 protein between cold and thawed (*), warm and thawed
(#), and Frozen and thawed conditions (^).The error bars represent standard
deviation (SD).
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15 I) HC-1 localized in endothelial cells and ependymal cells in anterior
brain close to LV
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15 II) HC-1 localized in endothelial cells and ependymal cells in anterior
brain close to LV
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Fig 15: HC-1 localization in endothelial cells and ependymal cells in anterior
brain close to LV. Confocal images presenting co-localization of HC-1
proteins in lateral ventricles (LV) region from anterior brain tissue of Gray
tree frog, Hyla chrysoscelis, under different physiological conditions. I) (a)
HC-1 was localized using rabbit anti-HC-1 primary antibody and Cy2
labeled goat anti-rabbit secondary antibody (Green). (b) Merge image (HC1/ Nuclei) the cell nuclei were counterstained using DAPI (Blue). (c) No
signal was detected in any part of front brain tissue when anti-HC-1 preabsorbed with corresponding antigen peptide. II) Images showing HC-1
signals on: apical surface of ependymal cells lining on lateral ventricle
(arrowhead), endothelial cell of blood vessels (arrow). Scale=50u, (*) is
blood vessels. Frog numbers (n=3).
Anterior brain/HC-1
Ependymal cells
Endothelial cells
Astrocytes close to BBB
Neurons

Warm
+++
++++
+
+

Cold
++++
++++
+
+

Frozen
+++
++++
+
+

Thawed
+++
++++
+
+

Table 1: Summary of the cellular localization of HC-1 in anterior brain from
different physiological conditions and illustrates the fluorescence signal
intensity differences between conditions.
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16 I) HC-1 localized in endothelial cells, ependymal cells, neurons, and
astrocytes in posterior brain close to AQ
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16 II) HC-1 localized in endothelial cells, ependymal cells, neurons, and
astrocytes in posterior brain close to OV
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Fig 16: HC-1 localization in endothelial cells, ependymal cells, neurons, and
astrocytes in posterior brain. Confocal images presenting co-localization of
HC-1 proteins in I) Aqueduct (AQ) and II) optic ventricles (OV) regions
from posterior brain tissue of Gray tree frog, Hyla chrysoscelis, under
different physiological conditions. (a) HC-1 was localized using rabbit antiHC-1 primary antibody and Cy2 labeled goat anti-rabbit secondary antibody
(Green). (b) Merge image (HC-1/ Nuclei) the cell nuclei were counterstained
using DAPI (Blue). No signal was detected in any part of front brain tissue
when anti-HC-1 pre-absorbed with corresponding antigen peptide. HC-1
signals were found on: apical surface of ependymal cells lining on lateral
ventricle (arrow head), endothelial cell of blood vessels (arrow), astrocytes
in contact with BBB (blocked arrow), neurons (dotted arrow). Scale=50u,
(*) is blood vessels. Frog numbers (n=3).
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Posterior brain/HC-1
Warm Cold Frozen Thawed
Ependymal cells
+++ ++++ +++
++
Endothelial cells of BBB +++ ++++ +++
++
Astrocytes close to BBB +++ ++++ +++
++
Neurons
+
+++
+
+

Table 2: Summary of the cellular localization of HC-1 in posterior brain
from different physiological conditions and illustrates the fluorescence
signal intensity differences between conditions.
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17 I) Warm brain:

17 II) Cold brain:

89

17 III) Frozen brain:

17 IV) Thawed brain:
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Fig 17: Co-localization of HC-1 with glial fibrillary acidic protein (GFAP)
on ependymal cells, neurons, and astrocytes. Confocal images presenting
double immune-labeling HC-1 with glial fibrillary acidic protein (GFAP) in
area close to lateral ventricles (LV) from anterior brain of Gray tree frog,
Hyla chrysoscelis, under different physiological conditions (I warm, II cold,
III frozen, IV thawed). (a) HC-1 was localized using rabbit anti-HC-1
primary antibody and Cy2 labeled goat anti-rabbit secondary antibody
(Green). (b) GFAP was localized using rabbit anti-GFAP primary antibody
and Cy3 labeled goat anti-rabbit secondary antibody (read). (e) Cell nuclei
were counterstained using DAPI (Blue). (d) HC-1 and GFAP were colocalized in the same areas (yellow): on apical surface of ependymal cells
lining on lateral ventricle (arrowhead), and in neurons (arrow), astrocytes
(blocked arrow). (e) Merge image (HC-1, GFAP, and nuclei). Scale=50u, (*)
is blood vessels. Frog numbers (n=3).

91

18 I) AQP4 localized in neurons and astrocytes in anterior brain close to LV
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18 II) AQP4 localized in neurons and astrocytes in anterior brain close to LV
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Fig 18: AQP4 localization in neurons and astrocytes in anterior brain close
to LV. Confocal images presenting co-localization of AQP4 proteins in
lateral ventricles (LV) region from anterior brain tissue of Gray tree frog,
Hyla chrysoscelis, under different physiological conditions. I) 20x
magnification (a) AQP4 was localized using rabbit anti-AQP4 primary
antibody and Cy2 labeled goat anti-rabbit secondary antibody (Green). (b)
Merge image (AQP4/ Nuclei) the cell nuclei were counterstained using
DAPI (Blue). (c) No signal was detected in any part of front brain tissue
when anti-AQP4 pre-absorbed with corresponding antigen peptide. II)
AQP4 signals on apical surface of ependymal cells lining on lateral ventricle
(arrow head), neurons (arrow), astrocytes (blocked arrow). Scale=50u, (*) is
blood vessels. Frog numbers (n=3).
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Anterior brain/AQP4
Ependymal cells
Endothelial cells of BBB
Astrocytes close to BBB
Neurons

Warm
++++
+++

Cold
++
++

Frozen
++++
++++

Thawed
+++
+++

Table 3: Summary of the cellular localization of AQP4 in anterior brain
from different physiological conditions and illustrates the fluorescence
signal intensity differences between conditions.
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19 I) AQP4 localized in neurons and astrocytes in posterior brain close to
AQ
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19 II) AQP4 localized in neurons and astrocytes in posterior brain close to
OV
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Fig 19: AQP4 localization in neurons and astrocytes in posterior brain.
Confocal images of presenting co-localization of AQP4 proteins in I)
Aqueduct (AQ) and II) optic ventricles (OV) regions from posterior brain
tissue of Gray tree frog, Hyla chrysoscelis, under different physiological
conditions. (a) AQP4 was localized using rabbit anti-AQP4 primary
antibody and Cy2 labeled goat anti-rabbit secondary antibody (Green). (b)
Merge image (AQP4/ Nuclei) the cell nuclei were counterstained using
DAPI (Blue). No signal was detected in any part of front brain tissue when
anti-AQP4 pre-absorbed with corresponding antigen peptide. AQP4 signals
were found on: neurons (arrow), astrocytes in contact with BBB (blocked
arrow). Scale=50u, (*) is blood vessels. Frog numbers (n=3).
Posterior brain/AQP4
Ependymal cells
Endothelial cells of BBB
Astrocytes close to BBB
Neurons

Warm
+++
+++

Cold
++++
++++

Frozen
+++
+++

Thawed
++
++

Table 4: Summary of the cellular localization of AQP4 in posterior brain
from different physiological conditions and illustrates the fluorescence
signal intensity differences between conditions.
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20 I) Warm brain:

20 II) Cold brain:
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20 III) Frozen brain:

20 IV) Thawed brain:
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Fig 20: Co-localization of AQP4 with glial fibrillary acidic protein
(GFAP) on neurons, and astrocytes. Confocal images presenting double
immune-labeling AQP4 with glial fibrillary acidic protein (GFAP) in
area close to lateral ventricles (LV) from anterior brain of Gray tree frog,
Hyla chrysoscelis, under different physiological conditions (I warm, II
cold, III frozen, IV thawed). (a) AQP4 was localized using rabbit antiAQP4 primary antibody and Cy2 labeled goat anti-rabbit secondary
antibody (Green). (b) GFAP was localized using rabbit anti-GFAP
primary antibody and Cy3 labeled goat anti-rabbit secondary antibody
(read). (e) Cell nuclei were counterstained using DAPI (Blue). (d) AQP4
and GFAP were co-localized in the same areas (yellow): in neurons
(arrow), astrocytes (blocked arrow). (e) Merge image (AQP4, GFAP, and
nuclei). Scale=50u, (*) is blood vessels. Frog numbers (n=3).
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21 I) HC-9 localized in neurons and astrocytes in anterior brain clos to LV

102

21 II) HC-9 localized in neurons and astrocytes in anterior brain clos to LV

103

Fig 21: HC-9 localization in neurons and astrocytes in anterior brain clos to
LV. Confocal images presenting co-localization of HC-9 proteins in lateral
ventricles (LV) region from anterior brain tissue of Gray tree frog, Hyla
chrysoscelis, under different physiological conditions. I) (a) HC-1 was
localized using rabbit anti-HC-9 primary antibody and Cy2 labeled goat
anti-rabbit secondary antibody (Green). (b) Merge image (HC-9/ Nuclei) the
cell nuclei were counterstained using DAPI (Blue). (c) No signal was
detected in any part of front brain tissue when anti-HC-9 pre-absorbed with
corresponding antigen peptide. II) HC-9 signals on: specific groups of
neurons (arrow), and astrocytes (blocked arrow). Scale=50u, (*) is blood
vessels. Frog numbers (n=3).
Anterior brain/HC-9
Ependymal cells
Endothelial cells of BBB
Astrocytes close to BBB
Neurons in NA

Warm
+++
+++

Cold
+
+

Frozen
++
++

Thawed
++++
++++

Table 5 Summary of the cellular localization of HC-9 in anterior brain from
different physiological conditions and illustrates the fluorescence signal
intensity differences between conditions.
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22 I) HC-9 localized in neurons and astrocytes in posterior brain close to AQ

105

Fig22: HC-9 localization in neurons and astrocytes in posterior brain close to
AQ. Confocal images presenting co-localization of HC-9 proteins in I)
Aqueduct (AQ) regions from posterior brain tissue of Gray tree frog, Hyla
chrysoscelis, under different physiological conditions. (a) HC-9 was
localized using rabbit anti-HC-9 primary antibody and Cy2 labeled goat
anti-rabbit secondary antibody (Green). (b) Merge image (HC-9/ Nuclei) the
cell nuclei were counterstained using DAPI (Blue). No signal was detected
in any part of front brain tissue when anti-HC-9 pre-absorbed with
corresponding antigen peptide. HC-9 signals were found on: astrocytes in
contact with BBB (blocked arrow), neurons (dotted arrow). Scale=50u, (*) is
blood vessels. Frog numbers (n=3).
Posterior brain/HC-9
Warm Cold Frozen Thawed
Ependymal cells
Endothelial cells of BBB
Astrocytes close to BBB
+
++
+
+++
Neurons
+
++
+
+++

Table 6: Summary of the cellular localization of HC-9 in posterior brain
from different physiological conditions and illustrates the fluorescence
signal intensity differences between conditions.
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Mid brain/AQP4
Ependymal cells
line the ventricles
Endothelial cells of
BBB
Astrocytes close to
BBB
Neurons

Warm
-

Cold
-

Frozen
-

Thawed
-

-

-

-

-

++

+++

+++

+

++

+++

+++

+

Mid brain/HC-1
Ependymal cells
line the ventricles
Endothelial cells of
BBB
Astrocytes close to
BBB
Neurons

Warm
+++

Cold
+++

Frozen
+

Thawed
++

+++

+++

+++

+

++

++

+

+

++

++

+

+

Mid brain/HC-9
Ependymal cells
line the ventricles
Endothelial cells of
BBB
Astrocytes close to
BBB
Neurons

Warm
-

Cold
-

Frozen
-

Thawed
-

-

-

-

-

+

+

+

++

+

+

+

++

Table7: Summary of the cellular localization of HC-1, AQP4, and HC-9
in mid brain from different physiological conditions and illustrate the
fluorescence signal intensity differences between conditions.
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23)
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Fig23: Co localization of HC-1, AQP4, and HC-9 in neurons and
astrocytes. Confocal images presenting triple immune-labeling HC-1,
AQP4, and HC-9 in area close to lateral ventricles (LV) from anterior
brain of Gray tree frog, Hyla chrysoscelis, under frozen condition (a)
Merge image presenting the triple staining for HC-1, AQP4, and HC-9
with counterstaining DAPI for cell nuclei (Blue). (b) HC-1 was localized
using rabbit anti-HC-1 primary antibody and Cy5 labeled goat anti-rabbit
secondary antibody (magenta). (c) AQP4 was localized using rabbit antiAQP4 primary antibody and Cy2 labeled goat anti-rabbit secondary
antibody (Green). (d) HC-9 was localized using rabbit anti-HC-9 primary
antibody and Cy3 labeled goat anti-rabbit secondary antibody (read). (e)
Merge image showing HC-1, AQP4, and HC-9 were co-localized in the
same areas (arrow): neurons and astrocytes. (f) Merge image showing
(HC-1&AQP4) were co-localized in the same areas (arrow): neurons and
astrocytes. (g) Merge image showing (HC-1&HC-9) were co-localized in
the same areas (arrow): neurons and astrocytes. (h) Merge image
showing (AQP4& HC-9) were co-localized in the same areas (arrow):
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neurons and astrocytes. Scale=20u, (*) is blood vessels. Frog numbers
(n=3).
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